<DOC>
	<DOCNO>NCT02214771</DOCNO>
	<brief_summary>The study aim describe characteristic method management follow-up patient treat fidaxomicin Clostridium difficile infection ( CDI ) .</brief_summary>
	<brief_title>Description Use fidAxomicin Hospitalized Patients With Documented Clostridium diFficile iNfection managEment These Patients</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<criteria>Hospitalized patient Patient diagnose CDI Patient already include study Patient take part clinical trial field CDI</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Clostridium difficile infection CDI</keyword>
	<keyword>Observational</keyword>
	<keyword>Fidaxomicin recurrence</keyword>
	<keyword>France</keyword>
</DOC>